Therapeutic Effect of Sirolimus for Lymphangioleiomyomatosis Remaining in the Abdominopelvic Region After Lung Transplantation: A Case Report.

T Ito,M Suno, K Sakamoto, Y Yoshizaki, K Yamamoto, R Nakanishi, Y Hirano,M Irie,T Kurosaki,S Otani,M Yamane,S Sugimoto,K Miyoshi,T Oto

Transplantation Proceedings（2016）

引用 7|浏览4

暂无评分

摘要

•The E-LAM lesions remaining after LT for P-LAM improved with the SRL therapy.•SRL therapy improved the QOL in the patient with lymphedema caused by E-LAM lesions.•SRL and TAC could be used concomitantly after LT without a drug interaction.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要